Physician profile
Alberta Hanan
NPI 1053960187
$2,063.31
in general payments reported to CMS, 2019-2025
20 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $446 · 2022: $705 · 2023: $252 · 2024: $387 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $912.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $567.19 | 2021-2025 | |
| Exeltis, USA INC. | $229.52 | 2021-2025 | Slynd |
| Daiichi Sankyo INC. | $179.25 | 2021-2024 | Injectafer |
| Mayne Pharma Commercial LLC | $173.23 | 2023-2025 | |
| Astellas Pharma US INC | $171.02 | 2021-2025 | Veozah |
| Evofem Biosciences, INC. | $152.50 | 2022-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $104.79 | 2024-2025 | Myfembree |
| Organon LLC | $95.85 | 2022-2025 | Nexplanon, Nuvaring |
| Exact Sciences Corporation | $65.58 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $58.41 | 2022-2023 | |
| Amgen INC. | $57.46 | 2021 | |
| Therapeuticsmd, INC. | $43.84 | 2021-2022 | |
| Scynexis, INC. | $41.53 | 2022 | |
| Sage Therapeutics, LLC | $33.07 | 2024 | |
| Agile Therapeutics, INC. | $26.16 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $14.59 | 2022 | |
| Coopersurgical, INC. | $14.06 | 2021 | |
| Myovant Sciences INC. | $13.16 | 2022 | |
| Medicem INC. | $12.39 | 2021 | |
| Heron Therapeutics, INC. | $9.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberta Hanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.